Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same author

Multi-dimensional decoding of the TSPO signal in animal models of neuroinflammation using fluorescence-conjugated DPA714.

Journal of neuroinflammation·2026
Same author

Failed resolution of inflammation in intracerebral haemorrhage.

Nature reviews. Neurology·2026
Same author

Myelin debris uptake by macrophages and microglia: Resolution of foam cells with a series of novel cyclodextrins.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Metabolic Collapse in Acute CNS Injury: A Spatiotemporal Framework Linking Redox Failure, Ferroptosis, and Neurovascular Dysfunction.

Antioxidants & redox signaling·2026
Same author

The test-retest reproducibility of [<sup>11</sup>C]PK11195 positron emission tomography using Biograph Vision Quadra scanner.

EJNMMI research·2026
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Related Experiment Video

Updated: Sep 20, 2025

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

10.7K

Microglia in multiple sclerosis - pathogenesis and imaging.

Laura Airas1, V Wee Yong2

  • 1University of Turku, Turku, Finland.

Current Opinion in Neurology
|June 8, 2022
PubMed
Summary
This summary is machine-generated.

Persistent microglia activation drives injury in multiple sclerosis (MS). Positron emission tomography (PET) imaging detects this activation, offering insights into MS progression and treatment monitoring.

More Related Videos

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

33.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Related Experiment Videos

Last Updated: Sep 20, 2025

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

10.7K
Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

33.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Area of Science:

  • Neuroscience
  • Immunology
  • Radiology

Background:

  • Microglia are central nervous system immune cells crucial for protection.
  • Persistent microglia activation contributes to neurodegeneration in multiple sclerosis (MS).

Purpose of the Study:

  • To review microglia activation in MS.
  • To discuss the use of positron emission tomography (PET) for detecting microglia activation in MS.

Main Methods:

  • Review of existing literature on microglia activation in MS.
  • Discussion of PET imaging using the mitochondrial 18-kDa translocator protein (TSPO) ligand for detecting microglia.

Main Results:

  • Microglia activation contributes to neurotoxicity in MS through various mediators.
  • TSPO PET imaging reveals increased microglia activation in normal-appearing white matter preceding radiological signs of neurodegeneration.
  • PET-detected microglia activation correlates with MS progression.

Conclusions:

  • Microglial activation is a key driver of injury in MS.
  • PET imaging with microglia-specific ligands provides valuable insights into MS progression.
  • PET imaging can serve as a tool for monitoring treatment responses in MS.